Trial Profile

Phase 2 trial of Trans sodium crocetinate in Hypoxic Solid Tumor

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 23 Oct 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

23 Jun 2022 According to a Diffusion Pharmaceuticals media release, the company is discussing a clinical protocol design with the US Food and Drug Administration.
23 Mar 2022 New trial record
21 Mar 2022 According to a Diffusion Pharmaceuticals media release, the company Company intends to file the study protocol with the FDA and expects to commence the trial in the second half of 2022, subject to FDA feedback and the availability of clinical drug supply.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com